Startseite
Podcasts
Prevention is Cure Podcast
Ozempic & GLP-1 drugs - Why 90% Still Fail | Prevention is Cure Ep# 45

Ozempic & GLP-1 drugs - Why 90% Still Fail | Prevention is Cure Ep# 45

Prevention is Cure vor 3 Monaten

0:00

44:50

In this episode of Prevention Is Cure, Prof Grant Schofield and
Sam Schofield dive deep into the most explosive topic in
metabolic health right now - have we actually cracked weight loss
and aging? From the latest GLP-1 triple agonists showing 30% body
weight loss, to gene therapies that can reverse the age of
individual cells, the science is moving faster than most people
realise.But here's the uncomfortable truth: 9 out of 10 people
regain the weight when they stop. The "Ozempic personality" is
real. And the first human trial of Yamanaka factor therapy just
began.

We cover:

The 4 weight loss options (and which actually works long-term)

The newest GLP-1 drugs you've never heard of — and can't
pronounce

What "food noise" is and why killing it might cost you more
than hunger

Longevity escape velocity — the first person to live to 1,000
may already be born

Yamanaka factors and the science of reversing cellular age

Why Grant believes prescribing these drugs without behaviour
change is unethical

️ Prevention Is Cure with Prof Grant Schofield & Guest Host
Sam Schofield

Subscribe for conversations on metabolic health, longevity, and
the science of living well.

#weightloss #GLP1 #Ozempic #longevity #metabolichealth
#preventioniscure